Table 4.
Combinations of inhibitory KIR-HLA pairs and their frequencies in HPV and control Brazilian women from Paraná, Southern Brazil.
| Number of pairs | KIR-HLA | HPV patients n (%) |
Control n (%) |
|---|---|---|---|
| 1 pair | 2DL2/3-C1 | 3 (30.0) | 7 (61.5) |
| 2DL1-C2 | 7 (70.0) | 4 (38.5) | |
|
| |||
| 2 pairs | 2DL2/3-C1, 3DL1-Bw4 | 12 (46.2) | 16 (34.5) |
| 2DL2/3-C1, 2DL1-C2 | 7 (26.9) | 14 (29.0) | |
| 2DL1-C2, 3DL1-Bw4 | 4 (15.4) | 11 (23.6) | |
| 2DL1-C2, 3DL2-A3/11 | 2 (7.7) | 4 (9.1) | |
| 2DL2/3-C1, 3DL2-A3/11 | 1 (3.9) | 2 (3.7) | |
|
| |||
| 3 pairs | 2DL1-C2, 2DL2/3-C1, 3DL1-Bw4 | 14 (51.9) | 25 (76.3) |
| 2DL2/3-C1, 3DL1-Bw4, 3DL2-A3/11a | 7 (25.9) | 2 (5.3) | |
| 2DL1-C2, 2DL2/3-C1, 3DL2-A3/11 | 6 (23.0) | 5 (15.8) | |
| 2DL1-C2, 3DL1-Bw4, 3DL2-A3/11 | 0 (0) | 1 (2.6) | |
|
| |||
| 4 pairs | 2DL1-C2, 2DL2/3-C1, 3DL1-Bw4, 3DL2-A3/11 | 8 (100) | 12 (100) |
a P = 0.025; OR = 3.42; 95% CI = 2.45–18.22.